New Consensus Statements Recommend MRI and MRI-Targeted Biopsies for Monitoring Prostate Cancer After Negative Biopsy

New Consensus Statements Recommend MRI and MRI-Targeted Biopsies for Monitoring Prostate Cancer After Negative Biopsy
An expert panel of urologists and radiologists from the American Urological Association (AUA) and the Society of Abdominal Radiology (SAR) has issued a set of consensus statements indicating that MRI (magnetic resonance imaging)-targeted biopsies could be used to monitor patients with negative biopsy for prostate cancer. The consensus statements were published in the Journal of Urology and

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *